Related Experiment Videos
[Estrogens--a breast cancer risk?]
1Universitäts-Frauenklinik, Abteilung für gynäkologische Endokrinologie und Reproduktionsmedizin, Hamburg. braendle@uke.uni-hamburg.de
Therapeutische Umschau. Revue Therapeutique
|November 18, 2000
Summary
Breast cancer risk increases with age. However, early pregnancy may reduce risk, while factors like obesity and hormone therapy slightly increase it, though not mortality.
Area of Science:
- Oncology
- Epidemiology
- Reproductive Health
Context:
- Breast cancer is a leading cancer in women, with aging as a primary risk factor.
- Established risk factors include obesity, early menarche, and late menopause.
- Recent studies examine the link between hormone replacement therapy (HRT) and breast cancer incidence.
Purpose:
- To summarize key risk factors for breast cancer.
- To analyze the association between reproductive factors and breast cancer risk.
- To evaluate the impact of hormone therapy on breast cancer incidence and mortality.
Summary:
- Aging is the most significant risk factor for breast cancer.
- Early age at first full-time pregnancy is linked to reduced breast cancer risk.
- Long-term estrogen replacement therapy (ERT) and hormone replacement therapy (HRT) show a slight increase in incidence, primarily low-grade, receptor-positive tumors, without increased mortality.
Impact:
- Provides a concise overview of breast cancer risk factors for researchers and clinicians.
- Highlights the complex interplay between reproductive history, lifestyle, and hormone therapy in breast cancer development.
- Clarifies that the increased incidence associated with HRT/ERT is minimal and does not elevate mortality rates.